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Abstract
Background: There is an ongoing controversy over the relative merits of randomized controlled trials (RCTs) and
non-randomized observational studies in assessing efficacy and guiding policy. In this paper we examine male
circumcision to prevent HIV infection as a case study that can illuminate the appropriate role of different types of
evidence for public health interventions.
Discussion: Based on an analysis of two Cochrane reviews, one published in 2003 before the results of three RCTs,
and one in 2009, we argue that if we rely solely on evidence from RCTs and exclude evidence from well-designed
non-randomized studies, we limit our ability to provide sound public health recommendations. Furthermore, the
bias in favor of RCT evidence has delayed research on policy relevant issues.
Summary: This case study of circumcision and HIV prevention demonstrates that if we rely solely on evidence
from RCTs and exclude evidence from well-designed non-randomized studies, we limit our ability to provide sound
public health recommendations.
Background
Randomized controlled trials (RCTs) are widely regarded
as the most scientifically rigorous method of evaluating
the effect of interventions. However, there is an ongoing
controversy over the relative merits of RCTs and non-
randomized observational studies in assessing efficacy
and guiding policy. According to the prevailing view,
RCTs provide evidence far superior to observational stu-
dies. Evidence from observational studies by itself is reli-
able only if there is a very strong association between
the intervention and the effect, such as a relative risk
greater than 5 [1]. In the more usual case, one should
rely on observational studies to evaluate efficacy only if
for ethical or other reasons it is impossible to do an
RCT. Evidence from observational studies may be useful
to confirm that the results from RCTs apply in real life
settings, but it can never, in the absence of a very strong
association, provide conclusive evidence that an inter-
vention causes an effect [2]. The main argument for this
position is that adequate randomization is uniquely able
to detect causation unbiased by confounding factors,
because it balances known and unknown prognostic fac-
tors in the groups being compared.
Those who criticize this hierarchical view maintain
that no one study design has an absolute advantage over
any other design. On the whole, the results of any study,
however well designed, cannot be taken by themselves
to reveal the truth about the effect of an intervention.
All studies are subject to confounding and bias. Accord-
ingly, it is imperative to evaluate the totality of evidence,
while trying to correct and adjust for confounding and
trying to explain why there may be remaining differ-
ences in the results of existing studies [3].
Recently the debate has focused on whether investiga-
tors should include the results of observational studies
in systematic reviews, when well designed RCTs are
available. Those who argue for excluding observational
studies from such reviews point out that the results
from these studies are unreliable, by either under- or
overestimating the true effect size [2,4]. Those who
defend inclusion point out that when one focuses on
well-designed observational studies, the effect sizes tend
to be similar to RCTs, and that there is therefore no
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optimally inform practice and policy, it is important to
i n c l u d et h et o t a l i t yo fe v i d e n c ef r o mw e l l - d e s i g n e ds t u -
dies (randomized and observational) and to try to
explain discrepancies between the included studies
[3,5-7].
In this paper we will examine male circumcision to
prevent HIV infection as a case study that can illuminate
t h ea p p r o p r i a t er o l eo fd i f f e r e n tt y p e so fe v i d e n c ef o r
public health interventions. During the previous twenty
years, multiple observational studies in the aggregate
demonstrated a clear association between circumcision
and HIV infection. Despite such consistent evidence,
experts called for initiating RCTs because of the possibi-
lity of unknown confounders in the observational evi-
dence. Only after the results of three RCTs were available
was the public health community convinced that there
was sufficient evidence to initiate provision of circumci-
sion services in high prevalence areas [8-10].
We shall use this case to argue that ignoring or dis-
counting observational evidence is a serious methodolo-
gical error. To focus the analysis, we will compare two
systematic reviews performed by the influential
Cochrane Collaboration. The first assessed the evidence
from observational studies; the second only assessed the
evidence from recently completed RCTs. We limit our-
selves to a discussion of these two reviews, recognizing
that there are other reviews taking a different approach,
such as [11]. By observational studies we mean studies
where the intervention has not been assigned as a part
of the research project, in particular not assigned by
some random mechanism. The study subjects may be
followed after they have selected the intervention, or the
outcome may be measured long after the subjects
selected their interventions.
Although we do not question the methodological
advantages of RCTs, we argue that it is important to
recognize that in the case of complex public health
interventions the results from even well designed RCTs
in isolation rarely provide enough evidence to guide
sound public health policy. Only if we take into account
the observational data do we have enough evidence to
recommend circumcision as a public health policy to
prevent HIV infection. Data from observational studies
therefore need to be considered for inclusion and
included when appropriate in systematic reviews of
available evidence.
Discussion
The assumption that only RCTs can provide reliable
evidence for policy
The Cochrane Collaboration is an international network
dedicated to providing high quality systematic reviews of
health care interventions. It is recognized as setting the
standards for systematic reviews of evidence for the
effectiveness of particular interventions. During
the 1990s, based on data from multiple observational
studies showing differences in HIV infection among cir-
cumcised and uncircumcised men, several experts
recommended circumcision as a public health measure
[12]. A Cochrane review published in 2003, however,
concluded that there was no solid evidence that circum-
cision was effective:
Despite the positive results of a number of observa-
tional studies, there are not yet sufficient grounds to
conclude that male circumcision, as a preventive
strategy for HIV infection, does more good than
harm. The results of current ongoing RCTs will
need to be carefully considered before circumcision
is implemented as a public health intervention for
prevention of sexually transmitted HIV.... It would
be prudent for consumers to await the findings of
ongoing randomised trials before deciding on the
balance between benefits and risks of male circumci-
sion in the context of HIV infection [13] (p. 18).
The main reason for this negative conclusion was
selection bias:
Selection bias was problematic in all studies, and
results were potentially confounded by other risk
factors for transmission of HIV, such as sexual beha-
viour and religion. Circumcised and uncircumcised
groups (in cohort and cross-sectional studies) and
HIV-positive and HIV-negative groups (in case-con-
trol studies) were seldom balanced for all or most of
the ten risk factors that we identified as potential
confounders prior to the quality assessment ... Statis-
tical adjustments for measured confounding factors
were made in 14 of the 35 included studies. The
adjusted confounders differed across studies in num-
ber and type (p. 15).
A tt h et i m eo ft h i sr e v i e w ,t h r e eR C T sw e r ee i t h e ri n
planning stages or had already started. The reviewers
therefore saw no need to go into more detail with
regard to an evaluation of the evidence [13]. In particu-
lar, they did not request more detailed data about the
studies from the authors themselves in order to better
judge whether selection bias was an issue in those stu-
dies that did not adjust for risk factors. But even if they
had done so, it probably would not have altered their
conclusion, given their stance that “observational studies
are inherently limited by confounding which is unlikely
to be fully adjusted for” (p. 2).
A second Cochrane review in 2009, in clear contrast
to the negative conclusion in 2003, concludes quite
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Male circumcision can be considered as an effective
measure to partly prevent HIV acquisition in hetero-
sexual men. Current evidence is lacking for whether
it also confers protection for women. Policy-makers
can consider implementation of male circumcision
as part of prevention measures if considered feasible
and socially and culturally acceptable for local condi-
tions [14] (p. 21).
It is noteworthy that the 2009 review was based solely
on the evidence from the three RCTs that had been
published in 2005 and 2007. Instead of adding the evi-
dence from the RCTs to the existing review of the
observational studies published in 2003, the 2009 review
replaced the 2003 review as the authoritative review of
the effectiveness of circumcision. It is possible that the
authors assumed as background knowledge the observa-
tional studies examined previously, and therefore did
not refer to them in the 2009 report. Another more
likely explanation, however, is the view that once we
have well-conducted RCTs we no longer need to con-
sider evidence from observational studies because of its
inherent unreliability. The dramatic shift from conclud-
ing that even prudent individuals should not consider
circumcision, to an endorsement of circumcision as a
public health intervention to prevent female to male
transmission seems to presuppose the view that the
RCT evidence is the only evidence that matters. We
argue that this prevailing assumption cannot withstand
critical scrutiny.
Is circumcision causally related to risk reduction of HIV
infection?
Both versions of the Cochrane reviews examine the causal
role of circumcision in preventing HIV infection. The first
concluded that observational studies have not demon-
strated sufficiently that it is circumcision as such that pre-
vents HIV infection, whereas the second concluded that
RCTs have been able to identify this factor as contributing
causally to HIV infection. The principal reason for these
different conclusions is the impossibility of excluding con-
founders in observational studies, while RCTs are uniquely
able to isolate the effect of the intervention of interest, in
this case circumcision. Although this may be true for pla-
cebo-controlled drug trials where everything except the
active substance is the same in the two comparison
groups, this is generally not possible for an inherently
complex intervention such as circumcision to prevent HIV
infection, in which behavioral factors can interact with the
medical procedure to influence the outcome under investi-
gation. Obviously, the circumcision RCTs could not be
conducted as a double-blind investigation. The lack of
blinding with regard to the intervention received, as the
Cochrane reviewers point out, is unlikely to affect the out-
come assessment itself, as it is an objectively measured
endpoint, HIV infection established by laboratory analysis.
But since both the study personnel and the research parti-
cipants would know who was circumcised or not, the RCT
design cannot exclude differential distribution of beha-
vioral interventions by the study personnel in the two
groups (and thus the risk of HIV infection) independent of
circumcision. This unequal distribution of behavioral
interventions is independent of any effect circumcision
may have on the risk behavior of the subjects themselves,
as a result of circumcision.
Even though both the intervention (circumcision) and
the outcome (HIV infection) can be standardized and
objectively verified in an RCT, it is impossible to ensure
that everything else of potential causal relevance in the
two groups is exactly the same. For example, counseling
is provided to everyone, but both those who are circum-
cised and the counselors know who are circumcised.
Counseling may therefore be done differently in the two
groups. Being members of the research team with an
interest in proving the study hypothesis that circumci-
sion prevents HIV, the counselors might more inten-
sively counsel the circumcised group regarding risk
behavior. Also, suspecting that the fact of circumcision
might promote more risky behavior, the counselors
might be inclined to deliver more forceful counseling to
the circumcised group. Accordingly, it is possible that
the specific counseling provided to the circumcised
group causes the prevention of HIV infection, and not
circumcision itself. We are not suggesting this as a plau-
sible hypothesis for the RCT results; however, it does
reflect a potential confound in the RCT evidence, which
the Cochrane review did not address.
One also needs to monitor the effect of circumcision
on the risk behavior of study participants. Changes in
risk behavior following circumcision can complicate
assessment of the causal impact of circumcision itself.
A well designed RCT would, of course, monitor risk
behavior in the two groups, which these trials did; how-
ever, they found variable effects on risk behavior in the
two groups. The Ugandan trial did not report any differ-
ence in risk behavior in the two groups [10] whereas the
South African trial reported increased risk behavior in
the circumcised group [8]. Furthermore, the self-
reported risk behavior might be unreliable, because a
number of men became HIV positive in spite of report-
ing no risk behavior. In the Ugandan trial, for example
16 of the 67 infections occurred in men who reported
no sex partners or 100% condom use [10]. It is therefore
possible that there are unknown behavioral risk factors
that are influenced by circumcision and differential
reporting of risk behavior depending on group
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This is particularly a challenge because it is known from
other studies that behavioral change is quite volatile,
with a high level of risk behavior before circumcision,
followed by excellent compliance after the procedure,
but a return to previous levels of risk behavior some
time after circumcision [15]. If differential distribution
of risk behavior in the control and intervention groups
counts as a decisive argument against observational stu-
dies, it should also count as a decisive argument against
RCTs.
In the case of circumcision and HIV infection there is
an additional, more complex type of causal relationship.
Circumcision may be related to HIV infection via its
effect on sexually transmitted infections (STIs). It is
known that, in particular, ulcerative STIs such as syphi-
lis may increase HIV infection. If circumcision reduces
the risk of acquiring such STIs, this may explain the
relationship between circumcision and HIV infection,
even though circumcision has no direct, causal influence
on HIV infection. It is therefore important to control
for this risk factor when evaluating the causal role of
circumcision in preventing HIV infection. Even if a well
designed RCT demonstrates a clear difference in HIV
infection between the two groups, this is not in and of
itself a proof that circumcision has a causal effect inde-
pendent of prevention of STIs. This factor needs to be
controlled for in all types of studies. Only one of the
RCTs did this by giving the numbers objectively diag-
nosed with STDs in the two groups [9].
The point here is not to express skepticism about
whether circumcision has a causal role in HIV infection,
nor to claim that confounding or bias are likely explana-
tions of the protective effect demonstrated in the three
RCTs, but to show that the prevailing approach to
research evidence reflects an inherent bias against obser-
vational studies and in favor of RCTs. RCTs of complex
interventions can rarely be designed with pristine
experimental control; accordingly, they are subject to
biases that need to be assessed. Nevertheless, factors
that are considered decisive against the reliability of
observational studies, often are not considered or are
discounted when evaluating evidence from RCTs. In
other words, the methodological limitations of observa-
tional studies are exaggerated at the same time that
those of RCTs are underappreciated.
Importantly, the observational studies may help to
correct the methodological limitations of RCTs for the
evaluation of complex public health interventions. The
rigor of observational studies of circumcision and HIV
infection varies considerably. Although not all cross sec-
tional studies have controlled for all possible behavioral
confounders, many have controlled for quite a number
of them, and in total, there is little evidence that there is
an association between circumcision and behavioral risk
factors that would explain the relationship between cir-
cumcision and risk of HIV infection. Further confidence
comes from the several prospective studies where the
number of HIV infections in two groups of initially HIV
negative men, one circumcised and the other uncircum-
cised, were recorded [11]. These also confirm the
hypothesis of a causal relationship between circumcision
as such and HIV infection. These observational studies
contain considerable data indicating that behavioral and
other confounders cannot explain the relationship
between HIV infection and circumcision. Accordingly,
these data directly address the methodological questions
regarding whether prevention of HIV infection by cir-
cumcision can be proved by RCTs. Rather than dismiss-
ing these data, a better strategy would be to conclude
that we already know from the observational studies
that there is a likely causal relationship between circum-
cision and HIV infection, and that the RCT evidence
further confirms this. Whereas the RCT evidence by
itself is not sufficient to establish a causal relationship,
when combined with the observational data, there is
proof beyond a reasonable doubt. In sum, failure to con-
sider the relevant data from observational studies consti-
tutes a serious methodological error.
External validity: Will introduction of circumcision services
reduce HIV infection?
When deciding policy, we not only need to know
whether provision of circumcision protects against HIV
infection (in the setting of an RCT). We also would
want to know whether introduction of circumcision ser-
vices will reduce HIV infection in the population. Even
if we accept that circumcision has a causal role in HIV
infection, we cannot necessarily conclude from this that
implementing circumcision services will lead to a reduc-
tion in the incidence of HIV infection.
B a s e ds o l e l yo ne v i d e n c ef r o mt h et h r e eR C T si t
would be difficult to recommend a policy of promoting
circumcision. We would have to assume that the situa-
tion of a population studied in the clinical trial, and the
way circumcision was performed, is similar in all rele-
vant respects to the situation when future populations
decide to get circumcised. Specifically, we would have to
assume that there are no behavioral risk factors for HIV
infection that are associated with a decision to enter a
circumcision trial versus a decision to utilize circumci-
sion services promoted by public health authorities. This
possible bias cannot be controlled for in any RCT. This
is not merely a theoretical worry. A proportionally larger
number of high risk individuals may decide to get cir-
cumcised if a nationwide program was introduced, who
might subsequently increase risky behavior because they
believe themselves to be protected. Additionally, sexually
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if the perception is that circumcised men are less likely
to be HIV-positive. Both of these factors could increase
HIV infections and diminish or obliterate the positive
causal role of circumcision in preventing HIV infection
on a population level.
An additional weakness in the data from the RCTs is the
lack of assurance that the circumcision method used in an
RCT can be replicated in nationwide programs. Circumci-
sion was provided in specialized clinics, with highly trained
personnel, providing state of the art counseling. In particu-
lar, the trials included counseling to avoid any risk activity
in the period right after circumcision due to the increase
in risk of infection during this period. If circumcision is
introduced on a large scale, it is highly likely that longer
healing times after the procedure will be observed, and
less adherence to reduction in risk behavior. It is also pos-
sible that circumcision might increase risk of HIV infec-
tion for women. Finally, if scaled up, the strict procedures
for the performance of circumcision during a clinical trial
setting may not be replicable. Less adherence to steriliza-
tion procedures may in fact increase the risk of HIV infec-
tion. Finally, the RCTs at the time they were reviewed by
the Cochrane collaboration provided follow-up for no
more than two years, and they were all stopped earlier
than planned, providing even less data on longer term
effects. All of this implies that we do not know, based on
the evidence from only the RCTs, that there will be any
long term, large scale positive effects of policies imple-
menting circumcision at a population level.
If, on the other hand, we allow an equal consideration
of the observational evidence, we may be more confi-
dent that introduction of circumcision services will
reduce HIV infection. The cross-sectional studies pro-
vide long term data, and they focus on circumcision
practices in settings that are closer to what one would
reasonably expect in a nationwide program. While not
completely reducing uncertainty, taking this evidence
into consideration would strengthen the case for a pol-
icy promoting circumcision.
The results from the RCTs may overemphasize the
effects we can expect in reducing HIV infection on a
population level. Adult circumcision may not be as
effective in preventing HIV in the general population
because a relatively high number of adults will be
infected before they are circumcised. The results from
an adult HIV-negative population that is circumcised as
adults in an RCT may therefore not be generalizable to
what will happen if a public health circumcision pro-
gram is introduced in an adult population because most
HIV infections will occur before they are circumcised. If
age of circumcision is an issue, therefore, the results
from the three RCTs might overestimate the preventive
effect of circumcision.
What all of this demonstrates is that if we only had
the results from the three RCTs, we would have insuffi-
cient evidence to guide public policy. In this case, how-
ever, we do have substantial data from observational
research that complement and strengthen the results
from the RCTs, giving us sufficient confidence to
recommend circumcision as a public health intervention
to prevent HIV infection.
Ignoring observational studies leads to suboptimal policy
The 2003 Cochrane review essentially concluded that no
reliable evidence existed to infer that circumcision was
causally responsible for preventing HIV infection and
that it would therefore not be appropriate for indivi-
duals or policy makers to even consider introducing cir-
cumcision services. Based on the evidence available at
that time, we think it would have been more appropriate
to follow the recommendations published by experts a
few years earlier. In 1999, Halperin and Baily argued
that “The hour has passed for the international commu-
nity to recognize the compelling evidence that show a
significant association between lack of male circumci-
sion and HIV infection” [12] (p. 1814). Based on the
available evidence from observational studies, the
authors recommended that one should both make this
information available for individuals to make their own
choices, but also introduce public health interventions
aimed at increasing circumcision uptake. Public health
authorities should
￿ Provide communities with accurate balanced infor-
mation so that individuals can make informed
choices
￿ Provide training and resources needed to offer safe,
voluntary male circumcision in which pain is kept to
a minimum
￿ Begin investigations of the feasibility of acceptable
male-circumcision interventions in communities
with high HIV and STD seroprevalence where cir-
cumcision has traditionally not been practiced.
While it may have been necessary to conduct RCTs in
order provide more definitive evidence that could con-
vince policy makers, more careful thought should have
been given to how these trials should be designed and
conducted, given the predictable uncertainties with
regard to the additional evidence that one may obtain
from RCTs pointed out above. Paradoxically, we are not
able to provide much stronger recommendations than
the above even after the results of the RCTs. In particu-
lar, we do not know if it would be worthwhile to estab-
lish widespread circumcision services even in high
prevalence countries. Some key remaining uncertainties
include lack of evidence regarding acceptability in
Lie and Miller BMC Medical Research Methodology 2011, 11:34
http://www.biomedcentral.com/1471-2288/11/34
Page 5 of 7different cultural groups, cost effectiveness, and applic-
ability of the results to real life settings. Rather than
conducting three trials with essentially similar cohorts
and similar intervention strategies, a better strategy
might have been to start one such trial and conduct a
second “pragmatic” trial with an intervention strategy
closer to what one could expect when circumcision ser-
vices are implemented, by using for example cluster ran-
domization by communities rather than individual
randomization. In this second trial infection in women
could also be monitored, as there is the possibility that
male circumcision might lead to an increase in HIV
infection in women. A cost-effectiveness analysis also
could have been incorporated into such a study. There
remain continued doubts about the cost-effectiveness of
a circumcision program compared with other, estab-
lished prevention programs, and there are doubts about
whether circumcision will be as effective when highly
active antiretroviral therapy is widely available for HIV
[16]. Existing cost-effectiveness studies are modeling
exercises and, although valuable, do not provide empiri-
cal data about how effective setting up circumcision ser-
vices actually are in preventing HIV infection [17].
Intersection of ethics and methodology
One should also consider the decision to stop all three
trials early as a potential source of bias [18,19]. The pre-
vailing ethics of clinical trials, oriented around the prin-
ciple of equipoise, reinforces the biases against
observational data and in favor of data from randomized
trials. According to this principle there must be a state
of equipoise regarding the benefit-to-risk ratio of the
interventions under investigation in order to justify ran-
domization, and trials must be stopped when this equi-
poise has been disturbed based on interim data [20].
Equipoise, suggesting indifference or at least uncertainty
regarding the preventive efficacy of circumcision with
respect to HIV, was possible at the outset of the three
RCTs only on the basis of discounting the substantial
observational data as not reflecting genuine knowledge.
Once emerging data from each of these trials indicated
statistically significant benefit from circumcision in
reducing the risk of becoming HIV-positive, equipoise
was disturbed, making it seem ethically imperative to
stop the trials. However, the prior observational research
supported the reasonable expectation that circumcision
would prove to be effective. If it was ethical to com-
mence the trial in the face of the observational data,
why should it have been ethically necessary to stop
them prematurely?
Stopping the three RCTs early diminished the knowl-
edge regarding the effects of circumcision with respect
to preventing HIV over time. Subjects entered the trial
with the expectation that they would have a 50% chance
of being circumcised and would be offered circumcision
free of charge after completion of the trial if they were
randomized to no circumcision. If it was reasonable and
fair to invite men to participate on these terms, then we
contend that it was also reasonable and fair to continue
the trial to its planned endpoint. All the subjects had
other means available to them to reduce their risk of
becoming HIV-positive, including use of condoms
and avoiding multiple sexual partners. The perceived
imperative to stop the trials and offer circumcision to all
the subjects confuses the individualistic, patient-centered
ethics of medical care–the therapeutic obligation to offer
optimal treatment–with the ethics of public health
research, aimed at informing health policy [21].
The prevailing ethical perspective mirrors the prevail-
ing epistemology. It is as if there was no knowledge at
all about the efficacy of circumcision prior to undertak-
ing RCTs and that definitive knowledge emerged as
soon as a statistically significant difference in efficacy
was detected in the RCT. Just as we need to correct
epistemic biases that overvalue RCTs and undervalue
well-designed observational research, so we need to cor-
rect ethical biases that needlessly impede the develop-
ment of policy-relevant knowledge.
Summary
This case study of circumcision and HIV prevention
demonstrates that if we rely solely on evidence from
RCTs and exclude evidence from well-designed non-
randomized studies, we limit our ability to provide
sound public health recommendations. One cannot, of
course, generalize from one case only. RCTs, however,
are increasingly being advocated for more complex pub-
lic health interventions [22], and even for use in evalua-
tion programs of anti-poverty programs by international
organizations such as the World Bank [23]. Our analysis
provides a reason to be skeptical of this trend, and it
strengthens recent criticism of the applicability of ran-
domized trials for public health in general [24] and for
interventions in developing countries in particular [25].
More importantly, our case study illustrates the need to
include all relevant studies in systematic analyses of evi-
dence, and not focusing exclusively on RCTs that satisfy
highly restrictive criteria. This is relevant for other inter-
ventions, as the ongoing controversy over the value of
mammography screening to prevent breast cancer illus-
trates. In this case also the Cochrane group left out of
their analysis a number of studies, thereby limiting the
value of the review. In sum, all study methods have
advantages and disadvantages with respect to rigor and
relevance to guiding practice and policy. Despite general
methodological advantages in determining causality,
RCTs have distinctive limitations in developing policy-
relevant knowledge. The hierarchical status that is
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in the field of public health. Combining evidence from
well-designed RCTs and observational studies optimally
informs public health policy.
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